Skip to main content
Search form
Search
Home
Clinical Diagnostics
Tests
By Disease
By Gene
By Panels
By Specialty
Clinical Diagnostic Exome
Clinical Exome Requirements
Carrier Screening and Prenatal
New York Approved
Turn-Around-Times
Specimen Requirements
Forms
Billing
CPT Codes
Send-Outs Consolidation
Institutional
Insurance
Medicare & Medicaid
Self Pay
International
For Patients
Order Kits
Reporting
AmbryPort
Licenses
Webinars
Genomic Services
Next Generation Sequencing
Illumina Sequencing
Ion Torrent Sequencing
Exome Sequencing
Targeted Enrichment
Microarrays
Agilent Microarrays
Roche NimbleGen Microarrays
ADME Sequencing
Genotyping
Bioinformatics
About
History
Our People
Executive Officers
Scientists
Clinical Directors
Genetic Counselors
Press
Corporate Citizenship
Mauli Ola Foundation
Daniella Maria Arturi Foundation
HHT
chILD Foundation
Contact
Careers
Careers
Fake Wide Bar
Press Releases
Thursday, January 19, 2012
Ambry Genetics Reports Results from Clinical Diagnostic Exome™ Testing of Three Patients
Wednesday, December 21, 2011
Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
Tuesday, November 29, 2011
Ambry Genetics turns to EMC Isilon for next-generation storage of gene sequencing.
Thursday, October 27, 2011
Agilent Technologies Signs Agreement to Supply Target Enrichment System to Ambry Genetics for Exome Sequencing
Monday, October 24, 2011
RainDance Technologies and Ambry Genetics Launch Industry’s Most Comprehensive DNA Sequencing Panel for ADME Research
Thursday, September 29, 2011
Ambry Genetics First to Offer Exome Sequencing Service for Clinical Diagnostics
Tuesday, September 20, 2011
Ambry Genetics RainDance's New ThunderStorm™ System for High-Throughput Next-Generation Targeted Sequencing Services
Wednesday, August 31, 2011
Ambry Genetics Announces Launch of their CancerArray™ Product and Services Utilizing aCGH Technology
Wednesday, June 15, 2011
Cell Line Genetics and Ambry Genetics Announce Exclusive Global Agreement For Sales of Ambry Genetics' StemArray™ and Related Services
Tuesday, April 19, 2011
Ambry Genetics Adds Certification of Roche NimbleGen CGH, DNA Methylation, Gene Expression, and ChIP-chip to Service Portfolio
Pages
1
2
3
4
next ›
last »
History
Our People
Press
Corporate Citizenship
Contact Us
Careers